id sid tid token lemma pos ffhd-110 1 1 the the DET ffhd-110 1 2 enhancing enhance VERB ffhd-110 1 3 effect effect NOUN ffhd-110 1 4 of of ADP ffhd-110 1 5 γ γ NOUN ffhd-110 1 6 - - PUNCT ffhd-110 1 7 cyclodextrin cyclodextrin NOUN ffhd-110 1 8 inclusion inclusion NOUN ffhd-110 1 9 on on ADP ffhd-110 1 10 γ γ NOUN ffhd-110 1 11 - - PUNCT ffhd-110 1 12 tocotrienol tocotrienol NOUN ffhd-110 1 13 - - PUNCT ffhd-110 1 14 dependent dependent ADJ ffhd-110 1 15 negative negative ADJ ffhd-110 1 16 growth growth NOUN ffhd-110 1 17 control control NOUN ffhd-110 1 18 of of ADP ffhd-110 1 19 mesothelioma mesothelioma NOUN ffhd-110 1 20 cells cell NOUN ffhd-110 1 21 in in ADP ffhd-110 1 22 a a DET ffhd-110 1 23 xenograft xenograft NOUN ffhd-110 1 24 model model NOUN ffhd-110 1 25 | | ADP ffhd-110 1 26 functional functional ADJ ffhd-110 1 27 foods food NOUN ffhd-110 1 28 in in ADP ffhd-110 1 29 health health NOUN ffhd-110 1 30 and and CCONJ ffhd-110 1 31 disease disease PROPN ffhd-110 1 32 online online PROPN ffhd-110 1 33 issn issn PROPN ffhd-110 1 34 : : PUNCT ffhd-110 1 35 2160 2160 NUM ffhd-110 1 36 - - SYM ffhd-110 1 37 3855 3855 NUM ffhd-110 1 38 ; ; PUNCT ffhd-110 1 39 print print NOUN ffhd-110 1 40 issn issn PROPN ffhd-110 1 41 : : PUNCT ffhd-110 1 42 2378 2378 NUM ffhd-110 1 43 - - SYM ffhd-110 1 44 7007 7007 NUM ffhd-110 1 45 skip skip NOUN ffhd-110 1 46 to to ADP ffhd-110 1 47 main main ADJ ffhd-110 1 48 content content NOUN ffhd-110 1 49 skip skip ADJ ffhd-110 1 50 to to ADP ffhd-110 1 51 main main ADJ ffhd-110 1 52 navigation navigation NOUN ffhd-110 1 53 menu menu NOUN ffhd-110 1 54 skip skip VERB ffhd-110 1 55 to to PART ffhd-110 1 56 site site VERB ffhd-110 1 57 footer footer ADJ ffhd-110 1 58 open open ADJ ffhd-110 1 59 menu menu NOUN ffhd-110 1 60 functional functional ADJ ffhd-110 1 61 foods food NOUN ffhd-110 1 62 in in ADP ffhd-110 1 63 health health NOUN ffhd-110 1 64 and and CCONJ ffhd-110 1 65 disease disease PROPN ffhd-110 1 66 online online PROPN ffhd-110 1 67 issn issn PROPN ffhd-110 1 68 : : PUNCT ffhd-110 1 69 2160 2160 NUM ffhd-110 1 70 - - SYM ffhd-110 1 71 3855 3855 NUM ffhd-110 1 72 ; ; PUNCT ffhd-110 1 73 print print NOUN ffhd-110 1 74 issn issn PROPN ffhd-110 1 75 : : PUNCT ffhd-110 1 76 2378 2378 NUM ffhd-110 1 77 - - SYM ffhd-110 1 78 7007 7007 NUM ffhd-110 1 79 home home NOUN ffhd-110 1 80 food food NOUN ffhd-110 1 81 science science NOUN ffhd-110 1 82 publisher publisher NOUN ffhd-110 1 83 functional functional ADJ ffhd-110 1 84 food food NOUN ffhd-110 1 85 center center NOUN ffhd-110 1 86 current current ADJ ffhd-110 1 87 archives archive NOUN ffhd-110 1 88 about about ADP ffhd-110 1 89 about about ADP ffhd-110 1 90 the the DET ffhd-110 1 91 journal journal NOUN ffhd-110 1 92 aims aim VERB ffhd-110 1 93 and and CCONJ ffhd-110 1 94 scope scope NOUN ffhd-110 1 95 contact contact NOUN ffhd-110 1 96 editing edit VERB ffhd-110 1 97 services service NOUN ffhd-110 1 98 editorial editorial ADJ ffhd-110 1 99 team team NOUN ffhd-110 1 100 express express VERB ffhd-110 1 101 peer peer NOUN ffhd-110 1 102 review review NOUN ffhd-110 1 103 graphical graphical ADJ ffhd-110 1 104 abstract abstract ADJ ffhd-110 1 105 journal journal NOUN ffhd-110 1 106 insights insight VERB ffhd-110 1 107 privacy privacy NOUN ffhd-110 1 108 statement statement NOUN ffhd-110 1 109 submissions submission NOUN ffhd-110 1 110 announcements announcement NOUN ffhd-110 1 111 search search NOUN ffhd-110 1 112 search search NOUN ffhd-110 1 113 register register NOUN ffhd-110 1 114 login login NOUN ffhd-110 1 115 home home NOUN ffhd-110 1 116 / / SYM ffhd-110 1 117 archives archive NOUN ffhd-110 1 118 / / SYM ffhd-110 1 119 vol vol NOUN ffhd-110 1 120 . . NOUN ffhd-110 1 121 1 1 NUM ffhd-110 2 1 no no NOUN ffhd-110 2 2 . . PROPN ffhd-110 2 3 12 12 NUM ffhd-110 2 4 ( ( PUNCT ffhd-110 2 5 2011 2011 NUM ffhd-110 2 6 ): ): PUNCT ffhd-110 2 7 december december PROPN ffhd-110 2 8 2011 2011 NUM ffhd-110 2 9 / / SYM ffhd-110 2 10 short short ADJ ffhd-110 2 11 report report NOUN ffhd-110 2 12 the the DET ffhd-110 2 13 enhancing enhance VERB ffhd-110 2 14 effect effect NOUN ffhd-110 2 15 of of ADP ffhd-110 2 16 γ γ NOUN ffhd-110 2 17 - - PUNCT ffhd-110 2 18 cyclodextrin cyclodextrin NOUN ffhd-110 2 19 inclusion inclusion NOUN ffhd-110 2 20 on on ADP ffhd-110 2 21 γ γ NOUN ffhd-110 2 22 - - PUNCT ffhd-110 2 23 tocotrienol tocotrienol NOUN ffhd-110 2 24 - - PUNCT ffhd-110 2 25 dependent dependent ADJ ffhd-110 2 26 negative negative ADJ ffhd-110 2 27 growth growth NOUN ffhd-110 2 28 control control NOUN ffhd-110 2 29 of of ADP ffhd-110 2 30 mesothelioma mesothelioma NOUN ffhd-110 2 31 cells cell NOUN ffhd-110 2 32 in in ADP ffhd-110 2 33 a a DET ffhd-110 2 34 xenograft xenograft NOUN ffhd-110 2 35 model model NOUN ffhd-110 2 36 authors author NOUN ffhd-110 2 37 t. t. PROPN ffhd-110 2 38 yano yano PROPN ffhd-110 2 39 research research PROPN ffhd-110 2 40 group group NOUN ffhd-110 2 41 of of ADP ffhd-110 2 42 nutritional nutritional ADJ ffhd-110 2 43 sciences science NOUN ffhd-110 2 44 , , PUNCT ffhd-110 2 45 faculty faculty NOUN ffhd-110 2 46 of of ADP ffhd-110 2 47 life life NOUN ffhd-110 2 48 sciences sciences PROPN ffhd-110 2 49 , , PUNCT ffhd-110 2 50 toyo toyo PROPN ffhd-110 2 51 university university PROPN ffhd-110 2 52 , , PUNCT ffhd-110 2 53 gunma gunma PROPN ffhd-110 2 54 , , PUNCT ffhd-110 2 55 374 374 NUM ffhd-110 2 56 - - SYM ffhd-110 2 57 0193 0193 NUM ffhd-110 2 58 a. a. NOUN ffhd-110 2 59 sato sato PROPN ffhd-110 2 60 research research NOUN ffhd-110 2 61 group group NOUN ffhd-110 2 62 of of ADP ffhd-110 2 63 nutritional nutritional ADJ ffhd-110 2 64 sciences science NOUN ffhd-110 2 65 , , PUNCT ffhd-110 2 66 faculty faculty NOUN ffhd-110 2 67 of of ADP ffhd-110 2 68 life life NOUN ffhd-110 2 69 sciences sciences PROPN ffhd-110 2 70 , , PUNCT ffhd-110 2 71 toyo toyo PROPN ffhd-110 2 72 university university PROPN ffhd-110 2 73 , , PUNCT ffhd-110 2 74 gunma gunma PROPN ffhd-110 2 75 , , PUNCT ffhd-110 2 76 374 374 NUM ffhd-110 2 77 - - SYM ffhd-110 2 78 0193 0193 NUM ffhd-110 2 79 m. m. NOUN ffhd-110 2 80 sekine sekine PROPN ffhd-110 2 81 research research PROPN ffhd-110 2 82 group group NOUN ffhd-110 2 83 of of ADP ffhd-110 2 84 nutritional nutritional ADJ ffhd-110 2 85 sciences science NOUN ffhd-110 2 86 , , PUNCT ffhd-110 2 87 faculty faculty NOUN ffhd-110 2 88 of of ADP ffhd-110 2 89 life life NOUN ffhd-110 2 90 sciences sciences PROPN ffhd-110 2 91 , , PUNCT ffhd-110 2 92 toyo toyo PROPN ffhd-110 2 93 university university PROPN ffhd-110 2 94 , , PUNCT ffhd-110 2 95 gunma gunma PROPN ffhd-110 2 96 , , PUNCT ffhd-110 2 97 374 374 NUM ffhd-110 2 98 - - SYM ffhd-110 2 99 0193 0193 NUM ffhd-110 2 100 k. k. PROPN ffhd-110 2 101 kashiwagi kashiwagi PROPN ffhd-110 2 102 department department PROPN ffhd-110 2 103 of of ADP ffhd-110 2 104 experimental experimental ADJ ffhd-110 2 105 pathology pathology PROPN ffhd-110 2 106 , , PUNCT ffhd-110 2 107 yokohama yokohama PROPN ffhd-110 2 108 city city PROPN ffhd-110 2 109 university university PROPN ffhd-110 2 110 graduate graduate NOUN ffhd-110 2 111 school school NOUN ffhd-110 2 112 of of ADP ffhd-110 2 113 medicine medicine NOUN ffhd-110 2 114 , , PUNCT ffhd-110 2 115 kanagawa kanagawa PROPN ffhd-110 2 116 , , PUNCT ffhd-110 2 117 315 315 NUM ffhd-110 2 118 - - PUNCT ffhd-110 2 119 0345 0345 NUM ffhd-110 2 120 m. m. NOUN ffhd-110 2 121 ota ota PROPN ffhd-110 2 122 research research NOUN ffhd-110 2 123 group group NOUN ffhd-110 2 124 of of ADP ffhd-110 2 125 nutritional nutritional ADJ ffhd-110 2 126 sciences science NOUN ffhd-110 2 127 , , PUNCT ffhd-110 2 128 faculty faculty NOUN ffhd-110 2 129 of of ADP ffhd-110 2 130 life life NOUN ffhd-110 2 131 sciences sciences PROPN ffhd-110 2 132 , , PUNCT ffhd-110 2 133 toyo toyo PROPN ffhd-110 2 134 university university PROPN ffhd-110 2 135 , , PUNCT ffhd-110 2 136 gunma gunma PROPN ffhd-110 2 137 , , PUNCT ffhd-110 2 138 374 374 NUM ffhd-110 2 139 - - SYM ffhd-110 2 140 0193 0193 NUM ffhd-110 2 141 doi doi NOUN ffhd-110 2 142 : : PUNCT ffhd-110 2 143 https://doi.org/10.31989/ffhd.v1i12.110 https://doi.org/10.31989/ffhd.v1i12.110 ADJ ffhd-110 2 144 abstract abstract ADJ ffhd-110 2 145 background background NOUN ffhd-110 2 146 : : PUNCT ffhd-110 2 147 malignant malignant ADJ ffhd-110 2 148 mesothelioma mesothelioma NOUN ffhd-110 2 149 is be AUX ffhd-110 2 150 an an DET ffhd-110 2 151 aggressive aggressive ADJ ffhd-110 2 152 cancer cancer NOUN ffhd-110 2 153 with with ADP ffhd-110 2 154 no no DET ffhd-110 2 155 effective effective ADJ ffhd-110 2 156 treatment treatment NOUN ffhd-110 2 157 options option NOUN ffhd-110 2 158 . . PUNCT ffhd-110 3 1 of of ADP ffhd-110 3 2 phytochemicals phytochemical NOUN ffhd-110 3 3 , , PUNCT ffhd-110 3 4 tocotrienol tocotrienol NOUN ffhd-110 3 5 ( ( PUNCT ffhd-110 3 6 t3 t3 PROPN ffhd-110 3 7 ) ) PUNCT ffhd-110 3 8 , , PUNCT ffhd-110 3 9 a a DET ffhd-110 3 10 member member NOUN ffhd-110 3 11 of of ADP ffhd-110 3 12 vitamin vitamin NOUN ffhd-110 3 13 e e NOUN ffhd-110 3 14 , , PUNCT ffhd-110 3 15 is be AUX ffhd-110 3 16 one one NUM ffhd-110 3 17 of of ADP ffhd-110 3 18 the the DET ffhd-110 3 19 most most ADV ffhd-110 3 20 potent potent ADJ ffhd-110 3 21 anti anti ADJ ffhd-110 3 22 - - ADJ ffhd-110 3 23 mesothelioma mesothelioma ADJ ffhd-110 3 24 agents agent NOUN ffhd-110 3 25 , , PUNCT ffhd-110 3 26 but but CCONJ ffhd-110 3 27 the the DET ffhd-110 3 28 effectiveness effectiveness NOUN ffhd-110 3 29 in in ADP ffhd-110 3 30 vivo vivo NOUN ffhd-110 3 31 is be AUX ffhd-110 3 32 quite quite ADV ffhd-110 3 33 limited limited ADJ ffhd-110 3 34 , , PUNCT ffhd-110 3 35 due due ADP ffhd-110 3 36 to to ADP ffhd-110 3 37 its its PRON ffhd-110 3 38 low low ADJ ffhd-110 3 39 bioavailability bioavailability NOUN ffhd-110 3 40 . . PUNCT ffhd-110 4 1 in in ADP ffhd-110 4 2 this this DET ffhd-110 4 3 study study NOUN ffhd-110 4 4 , , PUNCT ffhd-110 4 5 we we PRON ffhd-110 4 6 investigated investigate VERB ffhd-110 4 7 if if SCONJ ffhd-110 4 8 the the DET ffhd-110 4 9 oral oral ADJ ffhd-110 4 10 treatment treatment NOUN ffhd-110 4 11 of of ADP ffhd-110 4 12 γ γ PROPN ffhd-110 4 13 - - PUNCT ffhd-110 4 14 t3 t3 PROPN ffhd-110 4 15 inclusion inclusion NOUN ffhd-110 4 16 with with ADP ffhd-110 4 17 γ γ NOUN ffhd-110 4 18 - - NOUN ffhd-110 4 19 cyclodextrin cyclodextrin NOUN ffhd-110 4 20 ( ( PUNCT ffhd-110 4 21 cd cd PROPN ffhd-110 4 22 ) ) PUNCT ffhd-110 4 23 could could AUX ffhd-110 4 24 improve improve VERB ffhd-110 4 25 the the DET ffhd-110 4 26 bioavailability bioavailability NOUN ffhd-110 4 27 and and CCONJ ffhd-110 4 28 anticancer anticancer NOUN ffhd-110 4 29 activity activity NOUN ffhd-110 4 30 of of ADP ffhd-110 4 31 the the DET ffhd-110 4 32 t3 t3 PROPN ffhd-110 4 33 . . PUNCT ffhd-110 5 1 findings finding NOUN ffhd-110 5 2 : : PUNCT ffhd-110 5 3 using use VERB ffhd-110 5 4 nude nude ADJ ffhd-110 5 5 mice mouse NOUN ffhd-110 5 6 bearing bear VERB ffhd-110 5 7 msto-211h msto-211h PROPN ffhd-110 5 8 cells cell NOUN ffhd-110 5 9 ( ( PUNCT ffhd-110 5 10 a a DET ffhd-110 5 11 human human ADJ ffhd-110 5 12 malignant malignant ADJ ffhd-110 5 13 mesothelioma mesothelioma NOUN ffhd-110 5 14 cell cell NOUN ffhd-110 5 15 line line NOUN ffhd-110 5 16 ) ) PUNCT ffhd-110 5 17 , , PUNCT ffhd-110 5 18 the the DET ffhd-110 5 19 effect effect NOUN ffhd-110 5 20 of of ADP ffhd-110 5 21 γ γ PROPN ffhd-110 5 22 - - PUNCT ffhd-110 5 23 t3 t3 PROPN ffhd-110 5 24 inclusion inclusion NOUN ffhd-110 5 25 with with ADP ffhd-110 5 26 γ γ X ffhd-110 5 27 - - NOUN ffhd-110 5 28 cd cd NOUN ffhd-110 5 29 on on ADP ffhd-110 5 30 γ γ PROPN ffhd-110 5 31 - - PUNCT ffhd-110 5 32 t3 t3 ADJ ffhd-110 5 33 level level NOUN ffhd-110 5 34 in in ADP ffhd-110 5 35 tumor tumor NOUN ffhd-110 5 36 tissues tissue NOUN ffhd-110 5 37 , , PUNCT ffhd-110 5 38 tumor tumor NOUN ffhd-110 5 39 growth growth NOUN ffhd-110 5 40 , , PUNCT ffhd-110 5 41     SPACE ffhd-110 5 42 and and CCONJ ffhd-110 5 43 its its PRON ffhd-110 5 44 related related ADJ ffhd-110 5 45 mrna mrna NOUN ffhd-110 5 46 levels level NOUN ffhd-110 5 47 were be AUX ffhd-110 5 48 examined examine VERB ffhd-110 5 49 . . PUNCT ffhd-110 6 1 the the DET ffhd-110 6 2 difference difference NOUN ffhd-110 6 3 of of ADP ffhd-110 6 4 tumor tumor NOUN ffhd-110 6 5 growth growth NOUN ffhd-110 6 6 between between ADP ffhd-110 6 7 the the DET ffhd-110 6 8 two two NUM ffhd-110 6 9 groups group NOUN ffhd-110 6 10 had have VERB ffhd-110 6 11 no no DET ffhd-110 6 12 statistical statistical ADJ ffhd-110 6 13 significance significance NOUN ffhd-110 6 14 , , PUNCT ffhd-110 6 15 but but CCONJ ffhd-110 6 16 the the DET ffhd-110 6 17 latter latter NOUN ffhd-110 6 18 showed show VERB ffhd-110 6 19 a a DET ffhd-110 6 20 lower low ADJ ffhd-110 6 21 tendency tendency NOUN ffhd-110 6 22 compared compare VERB ffhd-110 6 23 with with ADP ffhd-110 6 24 the the DET ffhd-110 6 25 former former NOUN ffhd-110 6 26 . . PUNCT ffhd-110 7 1 in in SCONJ ffhd-110 7 2 linked link VERB ffhd-110 7 3 with with ADP ffhd-110 7 4 this this DET ffhd-110 7 5 observation observation NOUN ffhd-110 7 6 , , PUNCT ffhd-110 7 7 the the DET ffhd-110 7 8 level level NOUN ffhd-110 7 9 of of ADP ffhd-110 7 10 vascular vascular ADJ ffhd-110 7 11 endothelial endothelial ADJ ffhd-110 7 12 growth growth NOUN ffhd-110 7 13 factor factor NOUN ffhd-110 7 14     SPACE ffhd-110 7 15 mrna mrna PROPN ffhd-110 7 16 required require VERB ffhd-110 7 17 for for ADP ffhd-110 7 18 in in ADP ffhd-110 7 19 vivo vivo ADJ ffhd-110 7 20 tumor tumor NOUN ffhd-110 7 21 growth growth NOUN ffhd-110 7 22 in in ADP ffhd-110 7 23 γ γ PROPN ffhd-110 7 24 - - PUNCT ffhd-110 7 25 t3 t3 PROPN ffhd-110 7 26 inclusion inclusion NOUN ffhd-110 7 27 with with ADP ffhd-110 7 28 γ γ PROPN ffhd-110 7 29 - - ADJ ffhd-110 7 30 cd cd ADJ ffhd-110 7 31 group group NOUN ffhd-110 7 32 was be AUX ffhd-110 7 33 lower low ADJ ffhd-110 7 34 than than ADP ffhd-110 7 35 that that PRON ffhd-110 7 36 in in ADP ffhd-110 7 37 γ γ PROPN ffhd-110 7 38 - - PUNCT ffhd-110 7 39 t3 t3 PROPN ffhd-110 7 40 group group NOUN ffhd-110 7 41 , , PUNCT ffhd-110 7 42 on on ADP ffhd-110 7 43 the the DET ffhd-110 7 44 contrary contrary NOUN ffhd-110 7 45 , , PUNCT ffhd-110 7 46 the the DET ffhd-110 7 47 level level NOUN ffhd-110 7 48 of of ADP ffhd-110 7 49 γ γ PROPN ffhd-110 7 50 - - PUNCT ffhd-110 7 51 t3 t3 NOUN ffhd-110 7 52 level level NOUN ffhd-110 7 53 showed show VERB ffhd-110 7 54 an an DET ffhd-110 7 55 opposite opposite ADJ ffhd-110 7 56 tendency tendency NOUN ffhd-110 7 57 . . PUNCT ffhd-110 8 1 conclusion conclusion NOUN ffhd-110 8 2 : : PUNCT ffhd-110 8 3 our our PRON ffhd-110 8 4 study study NOUN ffhd-110 8 5 demonstrated demonstrate VERB ffhd-110 8 6 that that SCONJ ffhd-110 8 7 the the DET ffhd-110 8 8 bioavailability bioavailability NOUN ffhd-110 8 9 of of ADP ffhd-110 8 10 γ γ PROPN ffhd-110 8 11 - - PUNCT ffhd-110 8 12 t3 t3 PROPN ffhd-110 8 13 was be AUX ffhd-110 8 14 improved improve VERB ffhd-110 8 15 by by ADP ffhd-110 8 16 an an DET ffhd-110 8 17 oral oral ADJ ffhd-110 8 18 administration administration NOUN ffhd-110 8 19 of of ADP ffhd-110 8 20 a a DET ffhd-110 8 21 novel novel ADJ ffhd-110 8 22 γ γ PROPN ffhd-110 8 23 - - PUNCT ffhd-110 8 24 t3 t3 PROPN ffhd-110 8 25 inclusion inclusion NOUN ffhd-110 8 26 complex complex NOUN ffhd-110 8 27 with with ADP ffhd-110 8 28 cd cd PROPN ffhd-110 8 29 . . PUNCT ffhd-110 9 1 furthermore furthermore ADV ffhd-110 9 2 , , PUNCT ffhd-110 9 3 the the DET ffhd-110 9 4 improvement improvement NOUN ffhd-110 9 5 of of ADP ffhd-110 9 6 the the DET ffhd-110 9 7 bioavailability bioavailability NOUN ffhd-110 9 8 contributed contribute VERB ffhd-110 9 9 to to ADP ffhd-110 9 10 the the DET ffhd-110 9 11 increase increase NOUN ffhd-110 9 12 of of ADP ffhd-110 9 13 anticancer anticancer NOUN ffhd-110 9 14 activity activity NOUN ffhd-110 9 15 of of ADP ffhd-110 9 16 γ γ PROPN ffhd-110 9 17 - - PUNCT ffhd-110 9 18 t3 t3 NOUN ffhd-110 9 19 in in ADP ffhd-110 9 20 vivo vivo NOUN ffhd-110 9 21 . . PUNCT ffhd-110 10 1 keywords keyword NOUN ffhd-110 10 2 : : PUNCT ffhd-110 10 3 anti anti ADJ ffhd-110 10 4 - - ADJ ffhd-110 10 5 cancer cancer ADJ ffhd-110 10 6 agent agent NOUN ffhd-110 10 7 , , PUNCT ffhd-110 10 8 bioavailability bioavailability NOUN ffhd-110 10 9 , , PUNCT ffhd-110 10 10 cyclodextrin cyclodextrin NOUN ffhd-110 10 11 , , PUNCT ffhd-110 10 12 mesothelioma mesothelioma NOUN ffhd-110 10 13 , , PUNCT ffhd-110 10 14 tocotrienol tocotrienol NOUN ffhd-110 10 15 . . PUNCT ffhd-110 11 1 downloads download VERB ffhd-110 12 1 [ [ X ffhd-110 12 2 abstract abstract X ffhd-110 12 3 ] ] X ffhd-110 13 1 [ [ X ffhd-110 13 2 full full ADJ ffhd-110 13 3 article article NOUN ffhd-110 13 4 ] ] PUNCT ffhd-110 13 5 published publish VERB ffhd-110 13 6 2011 2011 NUM ffhd-110 13 7 - - SYM ffhd-110 13 8 12 12 NUM ffhd-110 13 9 - - SYM ffhd-110 13 10 30 30 NUM ffhd-110 13 11 issue issue NOUN ffhd-110 13 12 vol vol NOUN ffhd-110 13 13 . . PROPN ffhd-110 13 14 1 1 NUM ffhd-110 14 1 no no NOUN ffhd-110 14 2 . . PROPN ffhd-110 14 3 12 12 NUM ffhd-110 14 4 ( ( PUNCT ffhd-110 14 5 2011 2011 NUM ffhd-110 14 6 ): ): PUNCT ffhd-110 14 7 december december PROPN ffhd-110 14 8 2011 2011 NUM ffhd-110 14 9 section section NOUN ffhd-110 14 10 short short ADJ ffhd-110 14 11 report report NOUN ffhd-110 14 12 license license NOUN ffhd-110 14 13 authors author NOUN ffhd-110 14 14 retain retain VERB ffhd-110 14 15 the the DET ffhd-110 14 16 copyright copyright NOUN ffhd-110 14 17 of of ADP ffhd-110 14 18 their their PRON ffhd-110 14 19 articles article NOUN ffhd-110 14 20 and and CCONJ ffhd-110 14 21 grant grant VERB ffhd-110 14 22 the the DET ffhd-110 14 23 functional functional ADJ ffhd-110 14 24 food food NOUN ffhd-110 14 25 center center NOUN ffhd-110 14 26 ( ( PUNCT ffhd-110 14 27 ffc ffc NOUN ffhd-110 14 28 ) ) PUNCT ffhd-110 14 29 and and CCONJ ffhd-110 14 30 its its PRON ffhd-110 14 31 journals journal NOUN ffhd-110 14 32 the the DET ffhd-110 14 33 right right NOUN ffhd-110 14 34 of of ADP ffhd-110 14 35 first first ADJ ffhd-110 14 36 publication publication NOUN ffhd-110 14 37 under under ADP ffhd-110 14 38 the the DET ffhd-110 14 39 terms term NOUN ffhd-110 14 40 of of ADP ffhd-110 14 41 the the DET ffhd-110 14 42 creative creative ADJ ffhd-110 14 43 commons common NOUN ffhd-110 14 44 attribution attribution NOUN ffhd-110 14 45 4.0 4.0 NUM ffhd-110 14 46 international international ADJ ffhd-110 14 47 license license NOUN ffhd-110 14 48 . . PUNCT ffhd-110 15 1 this this DET ffhd-110 15 2 license license NOUN ffhd-110 15 3 permits permit VERB ffhd-110 15 4 unrestricted unrestricted ADJ ffhd-110 15 5 use use NOUN ffhd-110 15 6 , , PUNCT ffhd-110 15 7 distribution distribution NOUN ffhd-110 15 8 , , PUNCT ffhd-110 15 9 and and CCONJ ffhd-110 15 10 reproduction reproduction NOUN ffhd-110 15 11 in in ADP ffhd-110 15 12 any any DET ffhd-110 15 13 medium medium NOUN ffhd-110 15 14 , , PUNCT ffhd-110 15 15 including include VERB ffhd-110 15 16 commercial commercial ADJ ffhd-110 15 17 use use NOUN ffhd-110 15 18 , , PUNCT ffhd-110 15 19 provided provide VERB ffhd-110 15 20 the the DET ffhd-110 15 21 original original ADJ ffhd-110 15 22 author(s author(s NOUN ffhd-110 15 23 ) ) PUNCT ffhd-110 15 24 and and CCONJ ffhd-110 15 25 source source NOUN ffhd-110 15 26 are be AUX ffhd-110 15 27 properly properly ADV ffhd-110 15 28 credited credit VERB ffhd-110 15 29 . . PUNCT ffhd-110 16 1 authors author NOUN ffhd-110 16 2 may may AUX ffhd-110 16 3 post post VERB ffhd-110 16 4 and and CCONJ ffhd-110 16 5 share share VERB ffhd-110 16 6 their their PRON ffhd-110 16 7 published publish VERB ffhd-110 16 8 work work NOUN ffhd-110 16 9 freely freely ADV ffhd-110 16 10 , , PUNCT ffhd-110 16 11 provided provide VERB ffhd-110 16 12 that that SCONJ ffhd-110 16 13 the the DET ffhd-110 16 14 original original ADJ ffhd-110 16 15 publication publication NOUN ffhd-110 16 16 in in ADP ffhd-110 16 17 this this DET ffhd-110 16 18 journal journal NOUN ffhd-110 16 19 is be AUX ffhd-110 16 20 acknowledged acknowledge VERB ffhd-110 16 21 . . PUNCT ffhd-110 17 1 by by ADP ffhd-110 17 2 submitting submit VERB ffhd-110 17 3 to to ADP ffhd-110 17 4 this this DET ffhd-110 17 5 journal journal NOUN ffhd-110 17 6 , , PUNCT ffhd-110 17 7 authors author NOUN ffhd-110 17 8 confirm confirm VERB ffhd-110 17 9 that that SCONJ ffhd-110 17 10 their their PRON ffhd-110 17 11 manuscripts manuscript NOUN ffhd-110 17 12 are be AUX ffhd-110 17 13 original original ADJ ffhd-110 17 14 , , PUNCT ffhd-110 17 15 not not PART ffhd-110 17 16 under under ADP ffhd-110 17 17 consideration consideration NOUN ffhd-110 17 18 elsewhere elsewhere ADV ffhd-110 17 19 , , PUNCT ffhd-110 17 20 and and CCONJ ffhd-110 17 21 that that SCONJ ffhd-110 17 22 they they PRON ffhd-110 17 23 hold hold VERB ffhd-110 17 24 the the DET ffhd-110 17 25 necessary necessary ADJ ffhd-110 17 26 rights right NOUN ffhd-110 17 27 to to PART ffhd-110 17 28 grant grant VERB ffhd-110 17 29 this this DET ffhd-110 17 30 license license NOUN ffhd-110 17 31 . . PUNCT ffhd-110 18 1 the the DET ffhd-110 18 2 functional functional ADJ ffhd-110 18 3 food food NOUN ffhd-110 18 4 center center NOUN ffhd-110 18 5 encourages encourage VERB ffhd-110 18 6 open open ADJ ffhd-110 18 7 scientific scientific ADJ ffhd-110 18 8 exchange exchange NOUN ffhd-110 18 9 and and CCONJ ffhd-110 18 10 allows allow VERB ffhd-110 18 11 derivative derivative ADJ ffhd-110 18 12 and and CCONJ ffhd-110 18 13 extended extended ADJ ffhd-110 18 14 works work NOUN ffhd-110 18 15 , , PUNCT ffhd-110 18 16 provided provide VERB ffhd-110 18 17 attribution attribution NOUN ffhd-110 18 18 to to ADP ffhd-110 18 19 the the DET ffhd-110 18 20 original original ADJ ffhd-110 18 21 publication publication NOUN ffhd-110 18 22 is be AUX ffhd-110 18 23 maintained maintain VERB ffhd-110 18 24 . . PUNCT ffhd-110 19 1 about about ADP ffhd-110 19 2 the the DET ffhd-110 19 3 journal journal NOUN ffhd-110 19 4             SPACE ffhd-110 19 5 editing edit VERB ffhd-110 19 6 services service NOUN ffhd-110 19 7             SPACE ffhd-110 19 8 graphical graphical ADJ ffhd-110 19 9 abstract abstract ADJ ffhd-110 19 10             SPACE ffhd-110 19 11 journal journal NOUN ffhd-110 19 12 insights insight NOUN ffhd-110 19 13                 SPACE ffhd-110 19 14 submissions submission NOUN ffhd-110 19 15                 SPACE ffhd-110 19 16 editorial editorial ADJ ffhd-110 19 17 team team NOUN ffhd-110 19 18                 SPACE ffhd-110 19 19 privacy privacy NOUN ffhd-110 19 20 statement statement NOUN ffhd-110 19 21                 SPACE ffhd-110 19 22 contact contact NOUN ffhd-110 19 23                 SPACE ffhd-110 19 24 current current ADJ ffhd-110 19 25                 SPACE ffhd-110 19 26 archives archive NOUN ffhd-110 19 27     SPACE ffhd-110 19 28 open open ADJ ffhd-110 19 29 journal journal NOUN ffhd-110 19 30 systems system NOUN ffhd-110 19 31 hosting host VERB ffhd-110 19 32 and and CCONJ ffhd-110 19 33 support support NOUN ffhd-110 19 34 by by ADP ffhd-110 19 35 : : PUNCT ffhd-110 19 36 openjournalsystems.com openjournalsystems.com X